此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

提高乳房极度致密女性补充乳房 MRI 筛查的利用率

2026年9月10日 更新者:Abramson Cancer Center at Penn Medicine

The goal of this study is to increase MRI utilization among women with extremely dense breasts. The main question it seeks to answer is whether nudging of the provider, patient, or both increases the uptake of MRI among this group, and whether this effect differs between Black and White women.

研究概览

详细说明

Women with dense breasts have 3-5-fold increased risk for breast cancer as women without dense breasts. Dense breast tissue can "mask" small tumors, leading to reduced mammography sensitivity. Recent randomized controlled trials demonstrate that supplemental breast MRI screening improves detection of small, invasive cancers that are not detected by mammography. In January 2022, a Pennsylvania law went into effect mandating insurance coverage of supplemental screening for women with extremely dense breasts. Currently only a small fraction of eligible women with extremely dense breasts are receiving supplemental breast MRI screening. Clinical pathways to identify patients who are eligible for insurance coverage of supplemental breast MRI screening and communicate this option to patients and providers are needed to ensure equitable access to supplemental screening. This study therefore proposes a stepped wedge cluster randomized clinical trial to determine whether electronic health record (EHR) and secure text message nudges increase utilization of supplemental breast MRI screening among eligible women with extremely dense breasts.

研究类型

介入性

注册 (实际的)

1358

阶段

  • 不适用

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习地点

    • Pennsylvania
      • Bala-Cynwyd、Pennsylvania、美国、19004
        • University of Pennsylvania

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

40年 至 74年 (成人、年长者)

接受健康志愿者

不

有资格学习的性别

女性

描述

Patient participants:

Inclusion Criteria:

  • Women aged 40-74
  • Recent non-actionable mammogram of less than 6 months
  • Mammogram performed at Penn Center for Advanced Medicine, Penn Presbyterian Hospital, Pennsylvania Hospital, or Radnor
  • Valid mobile phone number

Exclusion Criteria:

  • Prior history of breast cancer
  • No breast MRI within the past 2 years
  • No prior actionable mammogram within 6 months
  • No recent or concurrent ultrasound

Provider participants:

Inclusion Criteria:

  • Provider needs to have ordered the initial screening mammogram
  • Employed by Penn Health System and access to Penn Chart

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 主要用途:放映
  • 分配:随机化
  • 介入模型:阶乘赋值
  • 屏蔽:无(打开标签)

武器和干预

参与者组/臂
干预/治疗
无干预:Usual care (no nudge)

Usual standard of care, no nudging.

实验性的:Provider nudge only

Nudge sent to provider through electronic health record (EHR).

Nudge directed to the provider with the aim of increasing ordering of MRI in patients with extremely dense breasts

实验性的:Patient nudge only

Nudge sent to the patient through text messaging.

Nudge directed to the patient with the aim of increasing the uptake of MRI in patients with extremely dense breasts

实验性的:Patient and provider nudge

Nudge sent to both provider through EHR, and to patient through text messaging.

Nudge directed to the provider with the aim of increasing ordering of MRI in patients with extremely dense breasts

Nudge directed to the patient with the aim of increasing the uptake of MRI in patients with extremely dense breasts

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Number of Patients for Whom Breast MRI Was Ordered and/or Scheduled
大体时间:6 months

Whether a breast MRI is ordered and/or scheduled within 6 months of the mammogram date

6 months

次要结果测量

结果测量
措施说明
大体时间
Number of Patients for Whom Breast MRI Was Ordered
大体时间:6 months

Whether an MRI is ordered within 6 months of the mammogram date. Analyzed separately from scheduling.

6 months
Number of Patients Who Scheduled a Breast MRI
大体时间:6 months

Whether an MRI is scheduled within 6 months of the mammogram date. Analyzed separately from ordering.

6 months
Number of Patients Who Completed a Breast MRI
大体时间:6 months

Whether an MRI is completed within 6 months of the mammogram date

6 months
False-positive Rate
大体时间:6 months

False-positive rate among those women who schedule and undergo MRI, defined as the number of patients who received a positive MRI result (i.e., BIRADS score of 4 or 5) but did not have a subsequent cancer diagnosis

6 months
Cancer Detection Rate
大体时间:6 months

Cancer detection rate among those women who schedule and undergo MRI

6 months

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

调查人员

  • 首席研究员:Anne Marie McCarthy, PhD、University of Pennsylvania

出版物和有用的链接

负责输入研究信息的人员自愿提供这些出版物。这些可能与研究有关。

一般刊物

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (实际的)

2023年10月4日

初级完成 (实际的)

2025年4月4日

研究完成 (实际的)

2025年4月4日

研究注册日期

首次提交

2023年3月15日

首先提交符合 QC 标准的

2023年3月15日

首次发布 (实际的)

2023年3月28日

研究记录更新

最后更新发布 (实际的)

2026年10月2日

上次提交的符合 QC 标准的更新

2026年9月10日

最后验证

2024年8月1日

更多信息

与本研究相关的术语

其他研究编号

  • UPCC 03123
  • P50CA244690 (美国 NIH 拨款/合同)
  • 852666 (注册表标识符:University of Pennsylvania Institutional Review Board)

计划个人参与者数据 (IPD)

计划共享个人参与者数据 (IPD)?

不

药物和器械信息、研究文件

研究美国 FDA 监管的药品

不

研究美国 FDA 监管的设备产品

不

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅